← All trials

NCT05637879

Phase 2/Phase 3Interventional

Trials that are a combination of phases 2 and 3.

View on ClinicalTrials.gov ↗

Timeline

Start date
Jul 1, 2023
Primary completion
Dec 31, 2025
Completion date
Sep 30, 2026
First posted
Dec 6, 2022
Last posted
Dec 14, 2022
Enrollment
92
Arms / groups
2 / —
Source
AACT · ctgov ingestion

Sponsors

Drugs studied

Indications studied

CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.